ALISA ELLISON: Open Payments
NPI 1578806105 · HINTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 21 payments from 8 companies in 2025. Trend: 2023 $348 · 2024 $377 · 2025 $408
Food & beverage: $402Education: $6
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $223 |
| Novo Nordisk Inc | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| ABBVIE INC. | 2 | $32 |
| Averitas Pharma Inc. | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $13 |
Products named: AIRSUPRA, FARXIGA, TRELEGY ELLIPTA, VRAYLAR, QUTENZA, Rybelsus, FANAPT, Ozempic.
Industry payments across WV — which companies pay providers there.
